MedTrace Logo

Diabetes Management Program for Hispanic/Latino

NCT03960424 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2023-10-16

No results posted yet for this study

Summary

To compare Diabetes Telemonitoring to comprehensive outpatient management (COM) on critical patient-centered outcomes, including HbA1c.

Conditions

Interventions

OTHER

Comprehensive Outpatient Management

Patients receiving comprehensive outpatient management experience typical care received in the outpatient setting.

BEHAVIORAL

Diabetes Telemonitoring

Diabetes Telehealth Management (DTM), based on the 2018 ADA Standards for T2D, uses smart devices to share information between patients, caregivers, and clinicians.

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Northwell Health

    lead OTHER

Principal Investigators

  • Renee Pekmezaris, PhD · Feinstein Institute for Medical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2023-03-12
Completion
2023-09-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03960424 on ClinicalTrials.gov